Brainbox LTD

Brainbox LTD, a for-profit corporation headquartered in Cardiff, United Kingdom with a secondary operational base in Bothell, Washington, manufactures and supplies transcranial focused ultrasound stimulation (TUS) and transcranial magnetic stimulation (TMS) systems to federal medical research agencies as a prime contractor. The vendor operates exclusively in full-and-open competition on small-dollar purchase orders, holding no SBA set-asides and competing on sole-source or competitive grounds based on equipment authorization and technical compatibility.

Brainbox's capability portfolio centers on neuromodulation hardware and supporting software for brain imaging and stimulation research. The vendor's product line includes the NEUROFUS PRO V2.0 and NEUROFUS DEEP transcranial focused ultrasound systems designed for modulating neural activity in deeper brain regions; the DuoMAG MP-Dual TMS system delivering monophasic paired pulses at variable stimulation intensity; NeuroFUST 2.0 transcranial ultrasound equipment; and the K-Plan software module for use with transducers in neural modulation research. Representative awards span the National Institute on Drug Abuse (NIDA), which procured a $139,028 sole-source NEUROFUS PRO V2.0 system with MRI-compatible transducer and training (November 2023 to November 2024); the National Institute of Neurological Disorders and Stroke (NINDS), which purchased a $47,006 DuoMAG MP-Dual TMS system (June 2026); and Veterans Integrated Service Network 1 (VA VHA VISN 1), which acquired a $183,455 NEUROFUS PRO turnkey system (September 2023 to September 2024).

Customer concentration is concentrated in medical research and veterans healthcare. The top five funding agencies account for 92% of awards by count and 97% of combined potential value. NIDA leads with five awards and $231 thousand combined potential value, followed by VA VHA VISN 1 ($183 thousand), VA VHA VISN 5 ($157 thousand), and the Army Medical Command ($91 thousand). The portfolio spans six federal agencies across the Department of Health and Human Services, Department of Veterans Affairs, and Department of the Army, with all twelve awards in the recent activity window concentrated in medical device supply (NAICS codes 334510, related electromedical apparatus manufacturing and analytical laboratory instrument manufacturing).

Activity is modest and episodic. The vendor has received twelve federal awards since 2013, with two awards in 2024, two in 2026, and single awards in 2020, 2022, and 2023. All twelve awards are prime contracts; the vendor holds no subcontract activity and sits on no parent vehicles, IDIQs, GWACs, or BPAs. Combined potential value across all awards totals $727 thousand, fully obligated. Two awards (combined potential value $67 thousand) carry ultimate completion dates in the next twenty-four months and face recompete exposure. The vendor operates with no federal subcontractors and competes independently on equipment procurements justified under sole-source authority (FAR Part 6.302-1) based on authorized distributor status or on competitive grounds where alternatives exist.